Cardea Bio

About:

Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.

Website: https://www.cardeabio.com/

Twitter/X: cardeabio

Top Investors: Agilent Technologies, Bill & Melinda Gates Foundation, Foothill Ventures, Alexandria Venture Investments, Taihill Venture

Description:

Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors. Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. With Cardean transistors, the company and its Innovation Partners can generate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type, and quality of biological data they capture by building products that Conduct Biolog.